For patients with ischemic stroke, tenecteplase administered within 4.5 hours after onset is an effective thrombolytic agent. Data on the use of tenecteplase beyond 4.5 hours are limited.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link:
#neurology #emergencymedicine #cardiology #clinicalmedicine #clinicaltrials #nejm
source
